▮
Home
▮
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Key Wallstreet Events
▮
Industry News
Technology
Software
Banking
Automotive
Energy
More
▮
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
▮
Earnings Calendars
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
▮
FDA Calendars
Drug Approvals
Clinical Trial Calendar
▮
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
▮
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Fed Members
▮
Crypto
Cryptocurrency
Blockchain
▮
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
▮
Politics
US
World
White House
Elections
General News
▮
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
▮
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
▮
Slide Shows
▮
Entertainment
Top Stories
Game of Thrones
▮
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
▮
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
▮
Premium
NEW
Intelligent Investor
Biotech Investor
NEW
Login
▮
More
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Home
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Key Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendars
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Fed Members
Crypto
Cryptocurrency
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Top Stories
Game of Thrones
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
NEW
Intelligent Investor
Biotech Investor
NEW
Login
More
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Immuneering Corp (IMRX)
Trade IMRX now with
Date
Headline
9/2/2022 8:59:33 AM
Immuneering Submits IND Application To FDA For Phase 1/2a Trial Of IMM-1-104 On Solid Tumors
9/2/2022 8:19:50 AM
Immuneering Submits IND Application To FDA For Phase 1/2a Trial Of IMM-1-104
12/28/2021 4:48:20 AM
12 Healthcare Stocks That Trade At Premium To Their IPO Price
Older Articles